Britannia Life Sciences Inc. (CSE:BLAB)
0.0650
-0.0050 (-7.14%)
Nov 20, 2026, 10:45 AM EST
Britannia Life Sciences Market Cap
Britannia Life Sciences has a market cap or net worth of CAD 11.4 million as of November 20, 2026. It is the 42,360th most valuable company in the world and the 1,445th biggest in Canada. Its market cap has decreased by 26.07% in one year.
Market Cap
11.40M
Enterprise Value
-806.56K
Revenue
406.44K
Global Rank
Country Rank
#1,445 Canada
PE Ratio
0.64
ChartMarket Cap Chart
Since November 18, 2021, Britannia Life Sciences's market cap has decreased from 41.95M to 11.40M, a decrease of -72.83%. That is a compound annual growth rate of -22.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 11.40M | -21.96% |
| Dec 31, 2025 | 14.60M | 12.50% |
| Dec 19, 2024 | 12.98M | 6.67% |
| Dec 29, 2023 | 12.17M | 7.14% |
| Dec 30, 2022 | 11.36M | -60.48% |
| Dec 31, 2021 | 28.74M | -31.48% |
| Nov 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Devonian Health Group | 17.52M |
| Alzai Health | 17.17M |
| Lobe Sciences | 16.98M |
| Medicenna Therapeutics | 16.61M |
| Pharmala Biotech Holdings | 14.81M |
| Rapid Dose Therapeutics | 13.09M |
| Onco-Innovations | 12.81M |
| PreveCeutical Medical | 12.76M |